NO20014987L - Substituerte azoler - Google Patents

Substituerte azoler

Info

Publication number: NO20014987L
Authority: NO; Norway
Prior art keywords: substituted azoles; azoles; substituted
Prior art date: 1999-04-14

Application number

NO20014987A

Other languages

English (en)

Norwegian (no)

Other versions

NO20014987D0 (no

Inventor

Laszlo Revesz

Achim Schlapbach

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2001-10-12

Publication date

2001-12-14

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

2001-10-12 Application filed by Novartis Ag filed Critical Novartis Ag

2001-10-12 Publication of NO20014987D0 publication Critical patent/NO20014987D0/no

2001-12-14 Publication of NO20014987L publication Critical patent/NO20014987L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Obesity (AREA)
Transplantation (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20014987A 1999-04-14 2001-10-12 Substituerte azoler NO20014987L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (en)	1999-04-14	2000-04-12	Substituted azoles

Publications (2)

Publication Number	Publication Date
NO20014987D0 NO20014987D0 (no)	2001-10-12
NO20014987L true NO20014987L (no)	2001-12-14

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014987A NO20014987L (no)	1999-04-14	2001-10-12	Substituerte azoler

Country Status (25)

Country	Link
US (1)	US6579874B2 (da)
EP (1)	EP1224180B1 (da)
JP (1)	JP2003503311A (da)
KR (1)	KR20010108504A (da)
CN (1)	CN1378544A (da)
AR (1)	AR023465A1 (da)
AT (1)	ATE244236T1 (da)
AU (1)	AU4295300A (da)
BR (1)	BR0010598A (da)
CA (1)	CA2370417A1 (da)
CO (1)	CO5170501A1 (da)
CZ (1)	CZ20013696A3 (da)
DE (1)	DE60003709T2 (da)
DK (1)	DK1224180T3 (da)
ES (1)	ES2202114T3 (da)
HU (1)	HUP0302747A2 (da)
IL (1)	IL145836A0 (da)
MX (1)	MXPA01010434A (da)
NO (1)	NO20014987L (da)
PE (1)	PE20010031A1 (da)
PL (1)	PL364789A1 (da)
PT (1)	PT1224180E (da)
SK (1)	SK14562001A3 (da)
TR (1)	TR200102967T2 (da)
WO (1)	WO2000063204A2 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2386218A1 (en)	1999-10-07	2001-04-12	Amgen Inc.	Triazine kinase inhibitors
DE60024480T2 (de) *	1999-10-27	2006-07-27	Novartis Ag	Thiazol und imidazo[4,5-b]pyridin verbindungen und ihre verwendung als pharmazeutika
US20030004174A9 (en) *	2000-02-17	2003-01-02	Armistead David M.	Kinase inhibitors
ATE430742T1 (de)	2000-12-21	2009-05-15	Smithkline Beecham Corp	Pyrimidinamine als angiogenesemodulatoren
EP1354603A1 (en) *	2000-12-26	2003-10-22	Takeda Chemical Industries, Ltd.	Concomitant drugs
US7199124B2 (en)	2001-02-02	2007-04-03	Takeda Pharmaceutical Company Limited	JNK inhibitor
KR20030080087A (ko)	2001-03-09	2003-10-10	화이자 프로덕츠 인코포레이티드	항염증제로서의 트리아졸로피리딘
WO2002072576A1 (en) *	2001-03-09	2002-09-19	Pfizer Products Inc.	Benzimidazole anti-inflammatory compounds
EP1247810B1 (en)	2001-04-04	2005-09-07	Pfizer Products Inc.	Novel benzotriazoles anti-inflammatory compounds
CA2450400A1 (en) *	2001-06-11	2002-12-19	Takeda Chemical Industries, Ltd.	Medicinal compositions
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
TWI231757B (en)	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
IL160081A0 (en)	2001-09-21	2004-06-20	Solvay Pharm Bv	Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
US20040259917A1 (en) *	2001-12-19	2004-12-23	Cosford Nicholas D.P.	Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
JP2005538066A (ja)	2002-07-09	2005-12-15	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規な抗コリン作用薬及びｐ３８キナーゼ阻害剤を用いた新規な医薬組成物
EP1581525A2 (en) *	2002-08-09	2005-10-05	AstraZeneca AB	Compounds having an activity at metabotropic glutamate receptors
IL166510A0 (en)	2002-08-09	2006-01-15	Nps Pharma Inc	1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
JP2006506340A (ja) *	2002-08-09	2006-02-23	アストラゼネカアクチボラグ	代謝調節型グルタミン酸受容体５のモジュレーターとしてのオキサジアゾール
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
EP1537107A2 (en) *	2002-08-30	2005-06-08	Pfizer Products Inc.	Novel processes and intermediates for preparing triazolo-pyridines
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
JP2006516548A (ja)	2002-12-30	2006-07-06	アンジオテックインターナショナルアクツィエンゲゼルシャフト	迅速ゲル化ポリマー組成物からの薬物送達法
WO2004069824A1 (ja)	2003-02-07	2004-08-19	Daiichi Pharmaceutical Co., Ltd.	ピラゾール誘導体
ATE334131T1 (de)	2003-02-14	2006-08-15	Pfizer Prod Inc	Triazolopyridine als entzündungshemmende verbindungen
MY143245A (en) *	2004-04-28	2011-04-15	Mitsubishi Tanabe Pharma Corp	4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
WO2006004142A1 (ja)	2004-06-30	2006-01-12	Banyu Pharmaceutical Co., Ltd.	ビアリール誘導体
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP3143926B1 (en) *	2006-02-08	2020-07-01	The General Hospital Corporation	Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
JP2010526781A (ja)	2007-04-30	2010-08-05	アボット・ラボラトリーズ	ジアシルグリセロールｏ−アシル転移酵素１型酵素の阻害剤
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
WO2009094224A1 (en)	2008-01-25	2009-07-30	Millennium Pharmaceuticals, Inc.	Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
US9139589B2 (en)	2009-01-30	2015-09-22	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
DK2432767T3 (da) *	2009-05-19	2013-09-30	Dow Agrosciences Llc	Forbindelser og fremgangsmåder til at kontrollere svampe
EP2322176A1 (en)	2009-11-11	2011-05-18	Almirall, S.A.	New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
TW201217365A (en)	2010-08-11	2012-05-01	Millennium Pharm Inc	Heteroaryls and uses thereof
WO2012021611A1 (en)	2010-08-11	2012-02-16	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
EP2603216A4 (en)	2010-08-11	2013-12-18	Millennium Pharm Inc	HETEROARYLE AND USES THEREOF
UY33671A (es)	2010-10-13	2012-04-30	Millenium Pharmaceuticals Inc	Heteroarilos y sus usos
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
WO2018159650A1 (ja) *	2017-02-28	2018-09-07	東レ株式会社	グアニジン誘導体及びその医薬用途
US12441707B2 (en)	2019-12-30	2025-10-14	Tyra Biosciences, Inc.	Indazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69433501T2 (de) *	1993-11-08	2004-11-04	Smithkline Beecham Corp.	Oxazole zur behandlung von zytokinvermittelten erkrankungen
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
DE69627006T2 (de) *	1995-08-10	2004-01-15	Merck & Co Inc	2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/en not_active Ceased
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 CA CA002370417A patent/CA2370417A1/en not_active Abandoned
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
- 2000-04-12 EP EP00922630A patent/EP1224180B1/en not_active Expired - Lifetime
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Withdrawn
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2003503311A (ja)	2003-01-28
EP1224180B1 (en)	2003-07-02
ES2202114T3 (es)	2004-04-01
AU4295300A (en)	2000-11-02
SK14562001A3 (sk)	2002-03-05
CA2370417A1 (en)	2000-10-26
TR200102967T2 (tr)	2002-01-21
CZ20013696A3 (cs)	2002-02-13
US20020049220A1 (en)	2002-04-25
WO2000063204A3 (en)	2002-05-23
HUP0302747A2 (hu)	2003-12-29
DK1224180T3 (da)	2003-10-20
DE60003709T2 (de)	2004-12-23
ATE244236T1 (de)	2003-07-15
NO20014987D0 (no)	2001-10-12
EP1224180A2 (en)	2002-07-24
BR0010598A (pt)	2002-02-05
CO5170501A1 (es)	2002-06-27
AR023465A1 (es)	2002-09-04
PT1224180E (pt)	2003-11-28
DE60003709D1 (de)	2003-08-07
IL145836A0 (en)	2002-07-25
US6579874B2 (en)	2003-06-17
MXPA01010434A (es)	2002-03-27
PL364789A1 (en)	2004-12-13
CN1378544A (zh)	2002-11-06
KR20010108504A (ko)	2001-12-07
WO2000063204A2 (en)	2000-10-26
PE20010031A1 (es)	2001-02-23

Publication	Publication Date	Title
DK1224180T3 (da)	2003-10-20	Substituerede azoler
NO20016115D0 (no)	2001-12-14	Substituerte heterocykelkondenserte gamma-karboliner
EE200100502A (et)	2002-12-16	Ühendid
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
ATA51899A (de)	2002-04-15	Handstempel
DE60018989D1 (de)	2005-04-28	N-carbamoyloxyalkyl-substituierte azolium-verbindungen
ATE360620T1 (de)	2007-05-15	Imidazolderivate
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
DK1070708T3 (da)	2004-05-10	Triazolderivater
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
NO20013769L (no)	2001-09-26	Kalsilytiske forbindelser
NO20020466L (no)	2002-03-20	Kalsilytiske forbindelser
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
NO20022927D0 (no)	2002-06-18	Substituerte pyrrazoler
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
DE10082008D2 (de)	2002-12-19	Ausbeulgerät
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
ATA107599A (de)	2002-06-15	Heizwasserbereiter
DE10085167T1 (de)	2002-11-07	Gangumschalteinrichtung
ATA732000A (de)	2004-04-15	Kachelofen

Legal Events

Date	Code	Title	Description
2004-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application